Showing results (261-270 of 453) with videos related to
Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract CancersTin-Yun Tang, Federico Nichetti, Ben Kaplan, et al.Journal of Neuro-Oncology|November 29, 2019
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastomaMartin van den Bent, Analia Azaro, Filip De Vos, et al.Scientific Reports|May 24, 2022
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiencesShuyang Yao, Funda Meric-Bernstam, David Hong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid TumorsJosep Tabernero, Rastislav Bahleda, Rodrigo Dienstmann, et al.Emerging Microbes & Infections|April 7, 2021
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamsterMarco Brustolin, Jordi Rodon, María Luisa Rodríguez de la Concepción, et al.Cancer Research Communications|June 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2018
Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human StudyDejan Juric, Jordi Rodon, Josep Tabernero, et al.Nature Communications|January 9, 2026
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adultsLeonie Mayer, Anahita Fathi, Hanna-Marie Weichel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumorsPaul Haluska, Heather M Shaw, Gretchen N Batzel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2023
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor CamonsertibEzra Rosen, Timothy A Yap, Elizabeth K Lee, et al.Pageof 46